(Q44744096)

5 December 2017

Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma (English)

1 reference

5 December 2017

0 references

0 references

1

1 reference

5 December 2017

9

Gabriel N Hortobagyi

1 reference

5 December 2017

8

Aman U Buzdar

1 reference

5 December 2017

Aysegul A Sahin

2

1 reference

5 December 2017

Terry L Smith

3

1 reference

5 December 2017

Ying Yang

4

1 reference

5 December 2017

Lajos Pusztai

5

1 reference

5 December 2017

Rita Nahta

6

1 reference

5 December 2017

Thomas A Buchholz

7

1 reference

5 December 2017

Sarah S Bacus

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

5 December 2017

1 reference

5 December 2017

100

1 reference

5 December 2017

499-506

1 reference

5 December 2017

3

1 reference

Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling

5 December 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

Overexpression of mitogen-activated protein kinase superfamily proteins unrelated to Ras and AF-1 of estrogen receptor alpha mutation in advanced stage human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

The MAPK signaling cascade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Signal transduction via the MAP kinases: proceed at your own RSK.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Extracellular signals and reversible protein phosphorylation: what to Mek of it all.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Measuring activation of kinases in mitogen-activated protein kinase regulatory network

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.11940

1 reference

7 January 2021

Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

NDF/heregulin-induced cell cycle changes and apoptosis in breast tumour cells: role of PI3 kinase and p38 MAP kinase pathways

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Molecular cloning of human p38 MAP kinase

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Distinct roles for phosphoinositide 3-kinase, mitogen-activated protein kinase and p38 MAPK in mediating cell cycle progression of breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Resistance to tamoxifen-induced apoptosis is associated with direct interaction between Her2/neu and cell membrane estrogen receptor in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Activation of the p38 mitogen-activated protein kinase pathway by estrogen or by 4-hydroxytamoxifen is coupled to estrogen receptor-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Hyperexpression of mitogen-activated protein kinase in human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Potential prognostic value of mitogen-activated protein kinase activity for disease-free survival of primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

The p38 and JNK pathways cooperate to trans-activate vitamin D receptor via c-Jun/AP-1 and sensitize human breast cancer cells to vitamin D(3)-induced growth inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Bisphosphonate Induced Growth Inhibition of Breast Cancer Cells is Augmented by p38 Inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11940

7 January 2021

Identifiers

DOI

10.1002/CNCR.11940

1 reference

5 December 2017

1 reference